Welcome to OBR Finance where we track the market performance of oncology companies and products, and compare our performance versus other indices.

To find out more about a company click on the company name to see a brief profile.

DJIA
10467.16 -30.72 (-0.29%)

OBR index

NASDAQ Composite
2251.69 0.00 (+0%)

OBR index

NASDAQ Biotech
822.41 0.00 (+0%)

OBR index

Industry Performance Indicators

Cancer Patient Volume

How is this calculated?
Source: IntrinsiQ, LLC

Cancer Drug Dollar Volume

How is this calculated?
Source: IntrinsiQ, LLC

OBR Index
948.51 0.00 (+0%)

OBR index

The OBR Index is a market capitalization index. The index is comprised of OBR Finance companies with market cap values over $50M. The sharp increase in the OBR Index value in February is due to a change in the parameters used to calculate the index.

OBR Finance Top 5 Winners

ZIOP $3.74 0.00 +0%
ONTY $3.55 0.00 +0%
OGXI $14.15 0.00 +0%
NWBO.OB $1.01 0.00 +0%
NVS $49.09 0.00 +0%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

OBR Finance Top 5 Losers

ZIOP $3.74 0.00 +0%
ONTY $3.55 0.00 +0%
OGXI $14.15 0.00 +0%
NWBO.OB $1.01 0.00 +0%
NVS $49.09 0.00 +0%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

bull OBR Bulls

ABII $74.90 $50.87 +47%
RGDX $2.81 $1.99 +41%
GENZ $69.79 $53.84 +30%
AZN $50.60 $45.32 +12%
IMGN $9.15 $8.32 +10%
What is a bull?

OBR Bullish Percentage: 24%

bear OBR Bears

AFFY $6.37 $18.98 -66%
GNVC $0.53 $1.27 -58%
PPHM $1.67 $3.09 -46%
MDVN $9.37 $17.22 -46%
EXEL $3.08 $5.52 -44%
What is a bear?

OBR Bearish Percentage: 76%

USOjulyaug

OBR Finance

Quotes Are Updated Every 20 Minutes.

Major Players: Market Cap > $50M (sorted descending by Market Cap)

Micro Cap < $50M (sorted descending by Market Cap)

Private, OTC & Foreign Exchange Companies

Acceleron Pharma, Inc.
Agios Pharmaceuticals Inc.
Ambit Biosciences
Antisense Pharma GmbH
Antisoma
Aposense Ltd.
Apthera, Inc.
Argos Therapeutics, Inc.
Arno Therapeutics, Inc.
Ascenta Therapeutics
Bayer Healthcare
BioNumerik Pharmaceuticals, Inc.
BioVex Inc.
BiPar Sciences, Inc.
Boehringer Ingelheim Corporation
Castle BioSciences Inc.
Celator Pharmaceuticals
Centocor Ortho Biotech Products, L.P.
Champions Biotechnology, Inc.
Clavis Pharma ASA
Concordia Pharmaceuticals, Inc.
Cornerstone Pharmaceuticals Inc.
Cytogen Corporation / EUSA
Eisai Inc.
EMD Serono, Inc.
Endocyte, Inc.
Epeius Biotechnologies Corporation
Esperance Pharmaceuticals
Five Prime Therapeutics, Inc.
Gemin X Pharmaceuticals
Genentech Inc. / Roche
Genmab, Inc.
GlobeImmune, Inc.
Gloucester Pharmaceuticals, Inc.
GPC Biotech AG
IRX Therapeutics
Jennerex Biotherapeutics Inc.
Light Sciences Oncology
Memgen
Merrion Pharmaceuticals, LLC
MethylGene Incorporated
Millennium: The Takeda Oncology Company
Neogenix Oncology Corporation
NeoPharm Inc.
Neotropix, Inc.
Nereus Pharmaceuticals, Inc.
NovaRx Corporation
Novogen Inc.
Oncolytics Biotech Inc.
OncoMed Pharmaceuticals, Inc.
Onconova Therapeutics Inc.
Orion Genomics
PDS Biotechnology Corporation
Plexxikon Inc.
Precision Therapeutics Inc.
Predictive Biosciences
Progen Pharmaceuticals Ltd.
Raven Biotechnologies, Inc.
Roche Inc.
S*BIO Incorporated
Semafore Pharmaceuticals
Syndax Pharmaceuticals, Inc.
The GI Company
Tigris Pharmaceuticals, Inc.
Tokai Pharmaceuticals, Inc.
TRACON Pharmaceuticals, Inc.
Transmolecular, Inc.
Veridex, LLC
Vion Pharmaceuticals Inc.
Xencor, Inc.